Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
The SBIR and STTR reauthorization brings larger awards, stricter eligibility and more competition for life sciences companies seeking federal funding.
PodcastManufacturers often overlook sales and use tax exposure. Learn where audits focus and how to reduce risk and recover overpayments.
Published by Medical Journal–Houston, Jerod Holloway examines how enterprise risk management is evolving across health care organization.
Success StoryShifting imaging volumes and competitive pressure challenged a hospital. Learn how our valuation analysis helped the hospital plan for a joint venture.
Four interested buyers. Operational and financial hurdles. A new ambulatory surgery center at a crossroads. Learn how Weaver guided valuation strategy.
Published by Medical Journal-Houston, Weaver's Corey Palasota explains the real reason behind how Houston's health care provider landscape has shifted in the past year.
Kurtis Dixon and Marvin Ferguson explain the tax benefits of AI in manufacturing, from R&D credits to expensing strategies.
Explore practical insight for women pursuing board leadership, including executive presence and other skills that support confident performance.
Explore regulatory drivers, private equity consolidation and emerging trends influencing health care valuation today.
Discover strategies to tackle tariffs and boost business resilience through smarter sourcing, planning and risk from Kurtis Dixon and Marvin Ferguson.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
HHS has adopted 2 CFR 200 and issued new implementation guidance at 2 CFR 300, replacing 45 CFR 75. Learn how the revised policy affects recipients.
